Sana Biotechnology to Present at Upcoming Investor Conferences
SEATTLE, Aug. 29, 2024 -- Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneer in engineered cell therapies, is set to showcase its work at three significant investor conferences this September. These presentations will offer a thorough overview of the company's business and the latest updates on its innovative projects.
Conference Presentation Schedule
Sana will be featured in the following investor events:
Morgan Stanley 22nd Annual Global Healthcare Conference
The first presentation is on September 4, 2024, at 11:30 a.m. ET. During this session, Sana will provide insights into its recent developments and future outlook through a focused business overview.
Wells Fargo Healthcare Conference
On September 5, 2024, Sana will take the stage at the 2024 Wells Fargo Healthcare Conference at 3:00 p.m. ET. This session is designed to update investors on the company's current advancements and strategic initiatives.
HC Wainwright 26th Annual Global Investment Conference
The last presentation of the month will occur on September 9, 2024, at 12:30 p.m. ET. This conference serves as a key opportunity for Sana to highlight its successes in engineered cell therapies.
Accessing the Presentations
All webcasts will be available on Sana’s Investor Relations page. After each presentation, replays will be accessible for 30 days, allowing stakeholders to catch up on the discussions and insights shared during the events.
About Sana Biotechnology
Sana Biotechnology, Inc. is dedicated to developing engineered cells as medicines that have the potential to revolutionize patient care. The company is focused on gene repair, replacement of missing or damaged cells, and expanding access to advanced therapies for various health conditions. With a committed team, Sana aims to reshape disease treatment globally and operates in multiple regions to ensure comprehensive coverage of its innovative efforts.
Investor Relations Contact
For any inquiries related to investor relations or media outreach, please contact:
Nicole Keith
investor.relations@sana.com
media@sana.com
Frequently Asked Questions
What is Sana Biotechnology known for?
Sana Biotechnology is recognized for its development of engineered cell therapies aimed at transforming patient treatment.
When and where will Sana present at investor conferences?
Sana will present on September 4, 5, and 9, 2024, at various investor conferences.
How can I access Sana's presentations?
You can access the presentations on Sana's Investor Relations webpage, with replays available for 30 days following the live events.
Who can be contacted for investor relations inquiries?
For inquiries, you can reach out to Nicole Keith at investor.relations@sana.com.
What can investors expect from the upcoming conferences?
Investors can look forward to detailed updates regarding Sana's business, innovative therapies, and future plans.